How to bring an orphan drug to market – why is there legislation for rare diseases?

By Carly / 25 June 2012 / 0 comments

Orphan drugs trainer Elizabeth Hernberg-Ståhl looks at why there is legislation for drugs for rare diseases in this video extract.

She discusses the Orphan Drug Act of 1983 and looks at the driving forces behind its introduction, as well as how it has helped to stimulate the orphan drugs industry since.

To find out more about the orphan drugs industry and the legislation involved, why not try a free sample of the online 12 Hour MBA in Orphan Drugs training course?

Feel free to contact me at carly.price@terrapinn.com if you have any queries!

Tags: orphan drug act, orphan drug legislation, Orphan Drugs, pharmaceuticals, video

Upcoming events

full event listing »

Training courses

full course listing »

Carly

I am the Marketing Manager for Terrapinn Training. We offer training courses covering the most important disciplines and markets, and I am interested in blogging on and hearing about an equally wide range of subjects, as well as anything to do with training and personal development.